// App-Quantinova.ai

e12029 : Predictive biomarkers of invasive carcinoma on excision in patients with a diagnosis of ductal carcinoma in situ of the breast by needle biopsy.

Researchers

Presenter

  • Miki Mori

Principal Investigators

  • Gregor Krings

  • Loretta Chan

  • Karla Kerlikowske

  • Thea D. Tlsty

  • Jean-Philippe Coppe

  • Naoko Matsuda

  • Koyu Suzuki

  • Seigo Nakamura

  • Laura van't Veer

  • Denise Wolf

  • Yunn-Yi Chen

Medical Centers

  • Department of Pathology, University of California, San Francisco, CA

  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CADivision of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, JapanDepartment of Breast Surgical Oncology, Showa University, Tokyo, Japan

  • University of California, San Francisco, San Francisco, CA

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • St.Luke's International Hospital, Tokyo, Japan

  • St.Luke's International Hospital, Tokyo, Japan

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • p53

  • Progesterone receptor

  • Cyclooxygenase-2

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved